Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Hepatoprotective agents in development at Korean labs

June 17, 1999

Ophidian in the process of expanding clinical development programs

June 10, 1999

New agents for IBS in development at Kyorin

June 10, 1999

Allelix's new treatment for short bowel syndrome advances to phase II

June 10, 1999

Ortho-McNeil presents basic research in the area of motilin antagonists

June 9, 1999

HAV vaccine prevents secondary hepatitis A infection

June 9, 1999

Stem cells provide lineage for liver cells, according to U. of Pittsburgh study

June 8, 1999

Journal alert: neostigmine is effective in the treatment of acute colonic pseudo-obstruction

June 3, 1999

Phase II HCV trial of Maxamine Therapy initiated

June 3, 1999

Dainippon establishes Korean partnership for mosapride citrate

June 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.